Cite
HARVARD Citation
Parodi, M. et al. (2013). Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation. Acta ophthalmologica. pp. 267-273. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Parodi, M. et al. (2013). Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation. Acta ophthalmologica. pp. 267-273. [Online].